Wow! This is how SABC’s supporters make a statement about how important research is for this disease. This year the “Moving to Cure Scleroderma” campaign presented $102,723.09 to the St. Paul’s Foundation for the SABC Research Project. Every dollar donated has gone to this local research. Our cheque presentation included SABC board members, Rosanne, Valerie & David, and members of the research group, Dr. James Dunne, Dr. Singhera, Bev Whalen & Raveen Badyal.

 

The growing support allows for this important research to continue. This, and other research in Canada, gives the scleroderma community hope. Thank you

 

To watch the “Moving to Cure Scleroderma” video of those that participated across the province CLICK HERE 

Thank you to all of you that participated and donated.

 


CLICK HERE to find out what the BC CDC is saying about the 3rd dose for scleroderma patients.


What is Scleroderma?

Scleroderma (systemic sclerosis or SSC) is a little known and incurable autoimmune disease, a condition in which a person’s immune system turns against itself by producing antibodies that attack its own tissues (i.e. autoantibodies).

Scleroderma affects approximately 2,300 people living in BC and 22,000 Canadians. Scleroderma is characterized by an overproduction of collagen and damage to the blood vessels that causes excessive scarring within the various organs.  This imbalance leads to a hardening of the skin (fibrosis) and an alteration of the affected organs. Moreover, in most cases, scleroderma limits the motor skills and dexterity of those affected and causes great physical and psychological suffering since it produces disfiguring appearance-related changes.

The skin, digestive system, heart, lungs, and kidneys are the organs most commonly affected by the potentially serious complications of scleroderma, which leads to significant decrease in quality of life and life expectancy. Read more

 

FORMS>

SYMPTOMS >

CAUSES>


Every donation counts

With your support, we can fight scleroderma!



Last updated : 2021 April 24